Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is a common side effect of hormone treatments for cancer.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.

Dermatologists are more accurate than general practitioners in diagnosing skin conditions, especially skin cancer.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

ChatGPT can be a helpful dermatology resource but should not replace professional consultations.

Increased PPARGC1α relates to hair thinning in common baldness.

A protein called sFRP4 can slow down hair regrowth.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Invasomes effectively deliver drugs through the skin and have potential for improved treatments.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Researchers found genes linked to hair loss in male giant pandas.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

CCCA and LPP may be related hair loss conditions influenced by genetics and environment, needing early treatment.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.